Given that TLR4 promotes the activity of proinflammatory cytokines such as TNF-α and IL-1β, which exacerbate MS inflammation, our finding that NGP is upregulated suggests that it may be involved in TLR4-associated pathways (57). The gene discussed is TLR4; the disease is myeloid sarcoma.